PharmEasy in talks to raise upto $300 million, valuation may drop by halfExisting investors will also put in $70 million, valuation at $2.5-$2.75 versus $5.4 billion of last year’s pre-IPO round. IPO is shelved f...
Thyrocare to stay focused on volumes, on time performance & qualityThe company is investing heavily on improving turnaround time and addressing quality perception of the brand in the market through a combin...
Watch out for these factors in Thyrocare as closely as you would watch any symptoms!Through strategic acquisitions in the healthcare space, the company seems to be aiming to create “a holistic healthcare ecosystem”. From th...
B2B payments fintech Rupifi raises $25 million funding led by Tiger, BessemerThe company now plans to use the proceeds from the fundraise to build the complete B2B checkout product for marketplaces as well as launch ...
Stocks in the news: Tarsons Products, HDFC, TCS, Bharti Airtel and Indiabulls HousingFitch Ratings has affirmed Bharti Airtel's long-term foreign currency Issuer Default Rating (IDR) and senior unsecured rating at 'BBB-.
Piramal Capital ties up with API HoldingsPiramal Capital & Housing Finance (PCHFL) has tied up with API Holdings to provide financing solutions to customers and has earmarked ₹100 ...
Indifi partners with Retailio to strengthen its presence in pharma sectorRetailio is used by retailers to order products from distributors and make payments to them. The company will now have a lending option as ...